Comparative hyperthermia effects of silica–gold nanoshells with different surface coverage of gold clusters on epithelial tumor cells
Received 10 May 2015
Accepted for publication 20 July 2015
Published 10 September 2015 Volume 2015:10(Special Issue on diverse applications in Nano-Theranostics) Pages 261—271
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Thomas Webster
Sang-Eun Park,1,* Jaewon Lee,2,* Taeksu Lee,2 Saet-Byeol Bae,1 Byunghoon Kang,2 Yong-Min Huh,3 Sang-Wha Lee,1 Seungjoo Haam,2
1Department of Chemical and Biochemical Engineering, Gachon University, Gyeonggi-Do, Republic of Korea; 2Department of Chemical Engineering, Yonsei University, Seoul, Republic of Korea; 3Department of Radiology, College of Medicine, Yonsei University, Seoul, Republic of Korea
*These authors contributed equally to this work
Abstract: Silica–gold nanoshell (SGNS), which is a silica core surrounded by a gold layer, was synthesized by seed-mediated coalescence of gold clusters in an electroless plating solution. SGNS variations with different surface coverage of gold clusters were prepared by adjusting the amounts of gold salts in the presence of formaldehyde-reducing agents. Fully covered SGNS (f-SGNS) with connected gold clusters exhibited stronger intensity and more redshift of plasmon bands located around 820 nm than those of partially covered SGNS (p-SGNS) with disconnected gold clusters. Upon irradiation with near-infrared light (30 W/cm2, 700–800 nm), f-SGNS caused a larger hyperthermia effect, generating a large temperature change (ΔT =42°C), as compared to the relatively small temperature change (ΔT =24°C) caused by p-SGNS. The therapeutic antibody, Erbitux™ (ERB), was further conjugated to SGNS for specific tumor cell targeting. The f-ERB-SGNS showed excellent therapeutic efficacy based on the combined effect of both the therapeutic antibody and the full hyperthermia dose under near-infrared irradiation. Thus, SGNS with well-controlled surface morphology of gold shells may be applicable for near-infrared-induced hyperthermia therapy with tunable optical properties.
Keywords: gold nanoshell, plasmon resonance, Erbitux, human epithelial cancer, hyperthermia
Recent applications of nanotechnology in medicine have focused on the fabrication of a hybrid core-shell nanostructure, known as a metal nanoshell, consisting of a dielectric core surrounded by a thin metallic layer for precise control of optical resonance that depends on the dielectric constant of the core materials and core–shell ratio.1–4 Hybrid nanoshells with tailored optical properties possess the highly tunable plasmon resonance of collective oscillations of free electrons across the visible into the near-infrared (NIR) region, where optical transmittance in the tissue is optimized. Tunable optical properties of nanoshells conjugated with targeting moieties or antibodies can provide noninvasive optical diagnosis and therapeutic payloads such as hyperthermia cancer therapy, photothermal-triggered drug release, and bio-imaging with cell targeting.5–9
Because of their biocompatible and/or noncytotoxic properties, gold composites with various dielectric cores such as Au2S, Polystyrene latex sphere, hollow sphere, nanomicelles, or silica nanorattles have been actively developed for biological applications.2,10–15 Gold nanoshells with a gold sulfide core are formed in a precisely controlled manner, but it is difficult to avoid generating gold nanoparticles (NPs) together with Au-coated Au2S NPs during the fabrication process.10 Polystyrene latex spheres with high monodispersity are used as dielectric cores because of their facile incorporation of organic dyes. Nonetheless, their plasmon resonances may not produce sufficient radiant local heating because of the low intensity of NIR absorption bands.11 A gold cage with strong NIR absorption can be prepared to less than 50 nm by simply adjusting the processing parameters.12,13 Nanomicelles with Au shells are designed to be multifunctional drug-delivery vehicles and to combine bio-imaging, targeting, and light-triggered drug release.14
Since the first report1 regarding seed-mediated fabrication of silica–gold nanoshell (SGNS) nearly two decades ago, numerous studies2–6,8,13–15 have focused on the fabrication of SGNS exhibiting robust structural integrity and the tunable optical resonance by simply adjusting the core–shell ratio across the metal interface, and there have been many attempts to utilize the strong NIR absorption of SGNS as a photo-triggered hyperthermia agent on the morbidity of tumor cells. However, there have been concerns regarding the potential human carcinogenicity of silica core materials.16 Hirsch et al observed photothermal destruction of carcinoma cells under NIR laser exposure (35 W/cm2) at 820 nm for 7 min, and all nanoshell-treated samples underwent photothermal destruction within the laser spot, which was determined by calcein AM viability staining.5 Hyeon et al also reported targeted NIR photothermal therapy against cancer cells using magnetic Au nanoshells at 800 nm under varied laser power densities from 2.5–10 W/cm2.17 Recently, Au nanorods have been employed for in vitro (or in vivo) photothermal destruction of cancer cells for different Au nanorods concentrations, NIR laser power densities, and irradiation times.18–20 However, the effect of Au shell thickness or surface coverage on the hyperthermia-induced destruction of cancerous cells remains unknown.
Therapeutic antibodies posses to not only specifically bind to corresponding tumor-specific and/or tumor-associated antigens but also kill tumor cells by blocking signaling pathways.21–23 Targeted delivery of plasmon-resonant NPs can enhance the selective killing of tumor cells while minimizing the toxicity to neighboring normal cells. One of the most promising targeting moieties for seeking cancerous cells is an antibody capable of specifically binding to tumor-specific antigens. Erbitux (ERB, cetuximab), a monoclonal therapeutic antibody, binds to the extracellular domain of epidermal growth factor receptor (EGFR) to prevent the activation and subsequent dimerization of the receptor, to decrease receptor activation and dimerization and result in inhibition of signal transduction and anti-proliferative effects.24–26 This agent may inhibit EGFR-dependent primary tumor growth and metastasis, in which EGFR is overexpressed on the cell surfaces of various solid tumors. Targeted cancer therapeutics using NIR-activated NPs will enable treatment of tumor cells with maximum efficacy while minimizing adverse side effects. In this method, ERB-conjugated nanoshells target human epithelial cancer cells through hyperthermia generated by NIR irradiation. The superficial anatomic location of epithelial cells enables the NIR laser beam to penetrate into tumor cells for photothermal destruction of tumor cells bound to nanoshell particles.27,28
In this study, SGNS were prepared by a seed-mediated electroless plating method. Small gold seeds were electrostatically deposited on amine-terminated silica NPs, followed by seed-mediated coalescence of gold clusters. The surface morphology of the Au shell (ie, the surface coverage and thickness of the Au layer) was controlled by adjusting the amounts of Au salts in the presence of formaldehyde reducing agents. Fully covered SGNS (f-SGNS) represent an Au shell with continuous (connected) gold clusters on the surface, while partially covered SGNS (p-SGNS) represent an Au shell with disconnected gold clusters on the surface. The hyperthermia effects on SGNS solution temperature were investigated by using particles with different surface coverage and thickness of Au shell, as well as particle concentration. Furthermore, ERB-conjugated SGNS with different surface coverages of Au clusters were examined for their ability to target and be taken up by human epithelial cancer cells, which overexpress the EGFR tumor antigen. We also report the killing effect of epithelial cancer cells through synergistic blocking of the signaling pathway by the therapeutic antibody and hyperthermia using a NIR laser.
Materials and methods
Chemical materials and analysis
3-Aminopropyl trimethoxysilane (97%), tetraethyl ortho-silicate (99.999%), tetrakis(hydroxymethyl) phosphonium chloride (80% solution), ammonium hydroxide (30%), formaldehyde (HCOH, 37%), L-ascorbic acid (C6H8O6, 99%), hydrogen tetra-chloroaurate (III) hydrate (HAuCl4, 99.99%), potassium carbonate (K2CO3, 99.7%), absolute ethanol (ETOH, 99.5%), and NaOH (semiconductor grade) were purchased from Sigma-Aldrich (St Louis, MO, USA) and used as received.
UV-Visible spectra were collected using an HP8453 UV-Visible spectrometer (Agilent Technologies, Santa Clara, CA, USA) in the range of 200–1100 nm. All samples were dispersed in water and loaded into a quartz cell for analysis. High-resolution scanning electron microscope images were obtained using a cold-type field emission gun scanning electron microscope operating at 15 kV accelerating voltage. The sample was placed and pressed onto double-sided conducting carbon tape supported by a copper plate. The X-ray diffraction patterns of the elemental composition were measured using a Rigaku D/MAX-2200 of 3 kW X-ray generator (using Cu Kα =1.5418 radiation) (Tokyo, Japan).
Synthesis of SGNS
The synthetic procedures were described in detail elsewhere.29,30 Colloidal silica were prepared using the Stöber method, which is based on the simultaneous hydrolysis and condensation of tetraethyl ortho-silicate by an ammonium hydroxide catalyst.31 Gold colloids (1-3 nm) were prepared by mixing 2.0 mL of 1.0 wt% tetrachloroaurate (III) trihydrate, 0.5 mL of 1.0 M NaOH, and 1.0 mL of 50 mM aqueous tetrakis (hydroxymethyl) phosphonium chloride, which is a powerfully reducing agent that can reduce gold salts via the derivation of formaldehyde.32 Next, the surface of silica NPs was functionalized using aminopropyltrimethoxy silane with a terminal amine group. Small Au seeds with negative charge were electrostatically attached onto the amine-terminated silica NPs. The Au seeds on the silica surface were grown by reducing the Au salts in the presence of formaldehyde reducing agents (80 to 120 μL), producing an Au layer. Au coverage on the silica NPs was adjusted by changing the concentration of reducible Au salts during the seed-mediated growth of Au clusters. The fabrication procedures are summarized in Figure 1.
Figure 1 Conceptual scheme of SGNS for tumor-specific targeting.
Cellular viability test of ERB-conjugated SGNS
The cytotoxic effect of ERB-conjugated SGNS in A431 and MCF7 cells was analyzed using a colorimetric assay based on the mitochondrial oxidation of 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT). A431 and MCF7 cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% antibiotics at 37°C under a 5% CO2 atmosphere. The cells were diluted to a density of 1.0×104 cells/100 μL in a 96-well plate and incubated at 37°C at 5% CO2. A431 and MCF7 cells were treated with various concentrations of ERB-conjugated SGNS (5.12×10−5 mg/L, ~20 mg/L) overnight and rinsed with 100 μL phosphate-buffered saline (pH 7.4, 1 mM), after which freshly-prepared MTT solution was added. The cells were further incubated for 4 h, and then 100 μL of solubilization solution (10% sodium dodecyl sulfate in 0.01 M HCl) was added. After overnight incubation, the absorbance of each well was measured using an enzyme-linked immunosorbent assay plate reader (Spectra MAX 340, Molecular Devices, Sunnyvale, CA, USA) at an absorbance wavelength of 575 nm and a reference wavelength of 650 nm. Cell viabilities were obtained by calculating the ratio of the intensity of purple formazan in viable cells treated with ERB-conjugated SGNS to the intensity in untreated control cells. This research is performed under the highest ethical and legal standards with the permission from the Ethics Committee of the Korean Biochip Society for the acquisition of human cells, cellular toxicity and photothermal assay tests.
In vitro photothermal experiments of ERB-conjugated SGNS
The epidermoid carcinoma A431 cell line and MCF7 cell line (with different levels of EGFR over-expression) were obtained from the American Tissue Type Culture (ATCC, Manassas, VA, USA) and cultured. Briefly, the cells (1×106 cells/mL) were seeded in 100Ø Corning culture dishes (10 mL/dish; Corning, NY, USA) with DMEM supplemented with 10% FBS and 1% antibiotics and incubated at 37°C in a humidified atmosphere containing 5% CO2. The A431 and MCF7 cell lines (1 × 104 cells/well) were incubated in 96-well plates for 24 h. The cells were incubated with ERB-SGNS (1.6×1010 particles/mL) at 37°C. After 1 h, free SGNS were removed by washing with an equal volume of 10% FBS. The cells treated with SGNS were then incubated within DMEM supplemented with 10% FBS and 1% antibiotics at 37°C.
After exposure to an NIR laser at 820 nm (35 W/cm2 for 5 min), the cells were further incubated for an additional 2 h at 37°C. Cell viability was determined using staining calcein AM (Molecular Probes, 1 μM) and by measuring the emission after excitation at 488 nm using a fluorescence spectrometer reader. The live/dead cell distribution after calcein AM staining was observed using a fluorescence microscope.
Results and discussion
SGNS with different surface coverage of Au clusters were prepared.30 The surface coverage of Au clusters over the silica NPs was controlled by adjusting the concentration of reducible Au salts relative to the number of silica NPs (1.5×1013/cm3).2 As shown in Figure 2, SGNS prepared with 0.38 mM of Au salts exhibited a rough surface morphology consisting of partial coverage of gold clusters, while SGNS prepared with 1.52 mM of gold salts exhibited a relatively smooth surface morphology with full coverage of Au clusters. Excessive addition of Au salts resulted in a significant reduction in plasmon bands due to the aggregation of gold NPs (data not shown).29
Figure 2 Scanning electron microscope images of SGNS (Silica core =120 nm) prepared by adding 80 μL of HCHO reducing agent and different amounts of Au salts: (A) 0.38 mM of Au salts, (B) 1.52 mM of Au salts.
Figure 3 shows the X-ray diffraction patterns of SGNS with different surface coverage of Au clusters. The sample solution was dropped onto a SnO2 glass more than 50 times to prepare a multi-layered deposition of SGNS. f-SGNS prepared with 1.52 mM Au salts exhibited a distinct X-ray diffraction peak attributed to the crystalline Au (111) phase. On the other hand, p-SGNS prepared by 0.38 mM gold salts exhibited a very similar X-ray diffraction pattern to Au seed-deposited silica NPs (Au-SiO2), and the amorphous silica layer was distinctly observed in both samples (p-SGNS and Au-SiO2), indicating significant exposure of the bare silica surface. The growth of deposited Au seeds did not produce full coverage of Au layer over silica cores when the Au salts were not sufficiently available.
Au-SiO2 NPs showed a characteristic absorption peak at 520 nm, corresponding to the Au seeds deposited on the silica NPs (data not shown). According to Figure 4, plasmon-derived absorption bands (plasmon bands) of SGNS ranged from 700–820 nm, depending on the surface coverage of Au clusters over silica cores.29,33 A strong plasmon band with a significant redshift was observed by f-SGNS, whereas p-SGNS exhibited a weak plasmon band with a less significant redshift. It is generally known that plasmon-derived absorption bands are strongly enhanced by plasmon couplings between adjacent Au clusters.34
In contrast, antibody-conjugated f-SGNS exhibited much lower optical intensity compared to bare f-SGNS. This may be because the entire surface of f-SGNS was conjugated with ERB antibodies, which induced a change in the dielectric environment and the agglomeration of SGNS via ERB linkage. However, ERB-bound p-SGNS (p-ERB-SGNS) exhibited a slightly more intense absorption peak compared to that of bare p-SGNS. The p-SGNS appeared to have fewer conjugation sites for the ERB antibody, leading to less inhibitive action for optical absorption of SGNS, and the conjugation of ERB was not effective on p-SGNS.24,26
The surface plasmon wave was propagated along the interface between the silica cores and Au shell layers, leading to the collective oscillation of plasmon electrons which can induce Au-layer heating, known as the hyperthermia effect. To investigate the photothermal response of p-SGNS and f-SGNS under NIR light irradiation, we used an NIR laser (30 W/cm2) at fixed wavelengths of 700 nm and 800 nm, corresponding to p-SGNS and f-SGNS, respectively. Figure 5A shows the temperature changes of the sample solution with increasing NIR irradiation times. The final temperature of the p-SGNS and f-SGNS solutions asymptotically approached 49°C and 67°C after exposure to the NIR laser for 800 sec. No significant temperature change was observed in pure water and Au-SiO2 (ΔT <10°C) under the same irradiation conditions. Thus, the conversion efficiency of NIR light to thermal energy was higher for f-SGNS with full coverage of the Au layer compared to that of p-SGNS with partial coverage of the Au clusters.
Temperature change of the sample solution under NIR irradiation was also dependent on the particle concentration. Over an elapsed time of 180 sec, solution temperature changes were investigated by diluting the original SGNS solution at room temperature. As shown in Figure 5B, the temperature change was proportional to the number of SGNS particles in the solution. At an elapsed time of 180 sec, the 10-fold diluted sample (0.15×1013/mL) had a final temperature of approximately 35°C, while 5-fold diluted sample (0.30×1013/mL) had a final temperature of >40°C. The two-fold diluted sample (0.75×1013/mL) and original sample (1.5×1013/mL) showed similar solution temperature changes until 60 sec, after which the original sample showed a more rapid increase in solution temperature compared to the 2-fold diluted sample. The final temperature difference between the original sample and the 2-fold diluted sample was approximately 5°C. When more than 0.75×1013/mL particles were used, a temperature change was not observed, likely because of the rapid thermal loss to the ambient environment.
Additionally, we investigated the hyperthermia effect of SGNS on the solution temperature depending on the Au shell thickness under NIR irradiation (820 nm, 30 W/cm2 for 3 min). According to Figure S1 and S2, SGNS with the thickest Au shell (Au shell thickness =35 nm) and the strongest absorption band showed a lower effective hyperthermia effect; the SGNS (Au shell =35 nm) exhibited a lower increase in solution temperature compared to the change for SGNS (Au shell thickness =20, 28 nm) with lower absorption bands. The hyperthermia effect is mainly attributed to the plasmon resonances occurring at the interface between the Au layer and the dielectric silica core. Thus, a thick Au layer may be less effective for generating a full hyperthermia effect at the interface because the absorbed light is prone to dissipation within the thick Au layer via bulk plasmon, leading to smaller increases in the solution temperature.35 In this work, an optimal thickness of the Au layer achieved an efficient hyperthermia effect, but disconnected Au clusters or a thick Au layer was not appropriate as the efficient hyperthermia agent.
Under NIR irradiation with 35 W/cm2 and for a spot diameter of 2 mm, cell death was observed on both p-ERB-SGNS- and f-ERB-SGNS-treated samples at 700 nm and 800 nm, respectively. Under control conditions (no nanoshell or nonspecific antibody), no cell death was observed, as shown in Figure 6. In vitro studies at high laser intensity indicated that the surface coverage of Au clusters had no significant effect on the photothermal triggered damage of tumor cells treated with p-ERB-SGNS and f-ERB-SGNS. Specifically designed photothermal nanomaterials have attracted attention because of their efficacy in treatment and because targeted NIR laser therapy does not require surgical intervention. Thus, the hybrid core-shell nanostructures, composed of metal nanoshells consisting of a dielectric core and metallic layer, are considered to be suitable photothermal probes in nanomedicine because of their highly tuneable surface plasmon resonance across the visible light into NIR region where optical transmittance in the tissue is optimized.2,3
Prior to photothermal ablation experiments using SGNS, we performed an MTT assay to measure the cytotoxicity of p-ERB-SGNS and f-ERB-SGNS. The target cells (A431 cells over-expressing EGFR and MCF7 cells lowly expressing EGFR) were treated with various concentrations of p-ERB-SGNS and f-ERB-SGNS (5.12×10−5 mg/L, ~20 mg/L) overnight and cell viabilities were analyzed (Figure 6). The results showed that cellular viability was higher than 80% in the presence of p-ERB-SGNS and f-ERB-SGNS, indicating low cytotoxicity within this concentration range.
To determine the turmoricidal efficacies of NIR laser treatment modalities, cancer cells were incubated with the prepared NPs after laser exposure. The therapeutic efficacies of p-ERB-SGNS and f-ERB-SGNS were then examined with respect to laser intensity and the concentration of SGNS against the cancer cell lines A431 and MCF7 cells with different EGFR overexpression levels. The viability of MCF7 and A431 cells was not influenced by the intensity of NIR-laser only (Figure 7, control). The f-ERB-SGNS- and p-ERB-SGNS-treated MCF7 cells showed strong emission after calcein AM staining. Calcein AM does not dye dead cells; this demonstrated that MCF7 cells did not heal by hyperthermia because of low EGFR receptor level. However, A431 cells had high EGFR receptor levels. Therefore, f-ERB-SGNS- and p-ERB-SGNS-treated A431 cells emitted weak light because of the hyperthermia effect from NIR-absorbing nanoshells (such as f-SGNS and p-SGNS). Particularly, we quantified cell viabilities after treatment with 0.4 mg/L of p-ERG-SGNS and 0.4 mg/L of f-ERB-SGNS by measuring the relative fluorescence intensities. The cellular viability of the control group was considered to be 100%. Cell viability after f-ERB-SGNS treatment of A431 cells was 20.57%±0.23% which was lower than that of p-ERB-SGNS (45.25%±1.5%). The therapeutic efficacy of f-SGNS was confirmed to be better than that of p-SGNS, which was expected based on the strong NIR absorbance of f-SGNS. Additionally, both p-ERB-SGNS- and f-ERB-SGNS-treated MCF7 cells showed relatively high cell viabilities (0.4 mg/L of p-SGNS-treated MCF7 cells: 98.95%±0.4% and 0.4 mg/L of f-SGNS-treated MCF7 cells: 98.95%±0.8%), indicating that there was no photothermal therapeutic effect on MCF7 cells caused by the antibody (ERB) on NP surface. Thus, we evaluated the increased therapeutic efficacy by f-ERB-SGNS under high-intensity NIR irradiation.
In summary, we examined the use of the therapeutic antibody ERB-conjugated SGNS for photothermal therapy of epithelial cancer cells. The surface morphology of the Au shell (surface coverage and thickness of the Au layer) was controlled by changing the relative amounts of Au precursors and reducing agents. Au layer with full surface coverage and optimal thickness is confirmed to induce the efficient hyperthermia effect of SGNS, whereas disconnected Au clusters or a thick Au layer is not recommended as an efficient hyperthermia agent. In addition, ERB on SGNS not only minimized the toxicities to neighboring normal cells, but also killed tumor cells by blocking signaling pathways.21,26
Silica-gold nanoshell (SGNS) was synthesized using seed-mediated growth into a clustered Au layer in an electroless plating solution. SGNS with different surface morphology of gold layer clusters was prepared by adjusting the amounts of gold salts and reducing agents. The hyperthermia effect of SGNS was systematically compared by using particles with different surface coverage and thickness of the Au layer. The f-SGNS showed more redshift and stronger absorption bands compared to those of p-SGNS. Upon irradiation with NIR light (30 W/cm2, 700–800 nm), f-SGNS exhibited higher efficiency of the hyperthermia effect (ΔT =42°C) compared to p-SGNS (ΔT =24°C). Furthermore, ERB-conjugated f-SGNS selectively recognized target cancer cell lines and showed excellent therapeutic efficacy because of the therapeutic antibody and NIR laser-induced hyperthermia effect.
This work was supported by the GRRC program of Gyeonggi province (GRRC Gachon 2014-B04, Development of Nanomaterials for Biomedical Sensing Applications) and was also supported by a grant (15172MFDS241) from Ministry of Food and Drug Safety in 2015.
The authors report no conflicts of interest in this work.
Westcott SL, Oldenburg SJ, Lee TR, Halas NJ. Formation and adsorption of clusters of gold nanoparticles onto functionalized silica nanoparticle surfaces. Langmuir. 1998;14:5396–5401.
Pham T, Jackson JB, Halas NJ, Lee TR. Preparation and characterization of gold nanoshells coated with self-assembled monolayers. Langmuir. 2002;18:4915–4920.
Prodan E, Radloff C, Halas NJ, Nordlander P. A hybridization model for the plasmon response of complex nanostructures. Science. 2003;302(5644):419–422.
Sauerbeck C, Haderlein M, Schürer B, Braunschweig B, Peukert W, Klupp Taylor RN. Shedding light on the growth of gold nanoshells. ACS Nano. 2014;8(3):3088–3396.
Hirsch LR1, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A. 2003;100(23):13549–13554.
Hirsch LR, Jackson JB, Lee A, Halas NJ, West JL. A whole blood immunoassay using gold nanoshells. Anal Chem. 2003;75(10): 2377–2381.
Yang X, Skrabalak SE, Li ZY, Xia Y, Wang LV. Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent. Nano Lett. 2007;7(12):3798–3802.
Loo C, Lin A, Hirsch L, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat. 2004;3(1):33–40.
Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2012;41(6):2256–2282.
Averitt R, Sarkar D, Halas N. Plasmon resonance shifts of Au-coated Au 2 S nanoshells: insight into multicomponent nanoparticle growth. Phys Rev Lett. 1997;78:4217–4220.
Shi W, Sahoo Y, Swihart MT, Prasad PN. Gold nanoshells on polystyrene cores for control of surface plasmon resonance. Langmuir. 2005;21(4):1610–167.
Chen JJ, Saeki F, Wiley BJ, et al. Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 2005;5(3):473–47.
Liu Z, Song H, Yu L, Yang L. Fabrication and near-infrared photothermal conversion characteristics of Au nanoshells. Applied Physics Letters. 2005;86:113109.
Ma Y, Liang X, Tong S, Bao G, Ren Q, Dai Z. Gold Nanoshell Nanomicelles for Potential Magnetic Resonance Imaging, Light-Triggered Drug Release, and Photothermal Therapy. Advanced Functional Materials. 2013;23:815–822.
Liu H, Chen D, Li L, et al. Multifunctional Gold Nanoshells on Silica Nanorattles: A Platform for the Combination of Photothermal Therapy and Chemotherapy with Low Systemic Toxicity. Angewandte Chemie. 2011;123:921–925.
Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. The Journal of Physical Chemistry B. 2006;110:7238–7248.
Kim J, Kim HS, Lee N, Kim T, Kim H, Yu T, Song IC, Moon WK, Hyeon T. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angewandte Chemie. 2008;47:8438–8441.
Lin J-T, Chiang Y-S, Lin G-H, Lee H, Liu H-W. In vitro Photothermal Destruction of Cancer Cells Using Gold Nanorods and Pulsed-Train Near-Infrared Laser. Journal of Nanomaterials. 2012:1–6.
Hong Y, Lee E, Choi J, et al. Gold Nanorod-Mediated Photothermal Modulation for Localized Ablation of Cancer Cells. Journal of Nanomaterials. 2012:1–7.
Popp MK, Oubou I, Shepherd C, Nager Z, Anderson C, Pagliaro L. Photothermal Therapy Using Gold Nanorods and Near-Infrared Light in a Murine Melanoma Model Increases Survival and Decreases Tumor Volume. Journal of Nanomaterials. 2014:1–8.
Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nature Medicine. 2000;6:443–446.
Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network, Nature reviews. Molecular Cell Biology. 2001;2:127–137.
Ridgway J, Zhang G, Wu Y, et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006;444:1083–1087.
Harari PM, Huang S. Radiation combined with EGFR signal inhibitors: head and neck cancer focus. Seminars in Radiation Oncology. 2006;16:38–44.
Dassonville O, Bozec A, Fischel JL, Milano G. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences. Critical Reviews in Oncology/Hematology. 2007;62:53–61.
Baselga J. The EGFR as a target for anticancer therapy – focus on cetuximab. European Journal of Cancer. 2001;37:16–22.
Choi J, Yang J, Park J, et al. Specific Near-IR Absorption Imaging of Glioblastomas Using Integrin-Targeting Gold Nanorods. Advanced Functional Materials. 2011;21:1082–1088.
Lee T, Bang D, Park Y, et al. Gadolinium-enriched polyaniline particles (GPAPs) for simultaneous diagnostic imaging and localized photothermal therapy of epithelial cancer. Advanced Healthcare Materials. 2014;3:1408–1414.
Park S, Park M, Han P, Lee S. Relative Contributions of Experimental Parameters to NIR-Absorption Spectra of Gold Nanoshells. J Ind Eng Chem. 2007;13:65–70.
Park S-E, Park M-Y, Han P-K, Lee S-W. The Effect of pH-adjusted Gold Colloids on the Formation of Gold Clusters over APTMS-coated Silica Cores. Bulletin of the Korean Chemical Society. 2006;27:1341–1345.
Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. Journal of Colloid and Interface Science. 1968;26:62–69.
Duff DG, Baiker A, Edwards PP. A new hydrosol of gold clusters. 1. Formation and particle size variation. Langmuir. 1993;9:2301–2309.
Park S-E, Lee J-W, Haam S-J, Lee S-W. Fabrication of double-doped magnetic silica nanospheres and deposition of thin gold layer. Bull Korean Chem Soc. 2009;30:869.
Xia Y, Halas NJ. Shape-Controlled Synthesis and Surface Plasmonic Properties of Metallic Nanostructures. MRS Bulletin. 2011;30:338–348.
Raether H. Surface Plasmons on smooth and rough surfaces and on gratings. Springer-Verag, New York, 1986.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]